4//SEC Filing
Rabinowitz Michael 4
Accession 0001209191-23-000517
CIK 0001176309other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 7:24 AM ET
Size
7.0 KB
Accession
0001209191-23-000517
Insider Transaction Report
Form 4
Rabinowitz Michael
Chief Commercial Officer
Transactions
- Sale
Common Stock
2023-01-03$12.49/sh−11,900$148,651→ 126,143 total - Sale
Common Stock
2023-01-03$13.01/sh−1,425$18,544→ 138,043 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 7, 2022.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.01 to $13.15, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the above range.
Documents
Issuer
ORAMED PHARMACEUTICALS INC.
CIK 0001176309
Entity typeother
Related Parties
1- filerCIK 0001876182
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 7:24 AM ET
- Size
- 7.0 KB